-
On Cancer and Identity
The first time Liza Bernstein was diagnosed with cancer, she wouldn't allow it to be part of her identity. After her third cancer diagnosis, she became an advocate for other patients.
by Liza Bernstein
-
Nothing but Time
A father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he'll be remembered.
by Adam P. Stern
-
When Cancer Becomes an Unwanted Priority
Amanda Rose Ferraro's leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.”
by Amanda Rose Ferraro
-
“Congrats! You Have the ‘Good’ Cancer”
Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.
by Carly Flumer
-
Finding Support in Unlikely Places
After her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles.
by Patricia Anne Ward
-
A Researcher Attends a Conference, This Time as a Patient Advocate
My most meaningful moments at my first cancer research conference came from embracing my experience as a patient—not as a researcher.
by Jamie Aten
-
Walking Back From Cancer
An American expat in Norway describes how a favorite walking trail aided him during treatment and recovery.
by Steven Ford
-
Coping With Trauma
Nearly six years after being diagnosed with stage IV colon cancer, disaster psychologist Jamie Aten is still learning new ways of coping with the trauma stemming from his diagnosis and treatment.
by Jamie Aten
-
What Not to Say to a Cancer Patient
When visiting a friend or family member who is sick, it's good to leave platitudes at the door.
by Michael Gavaghen
-
The Education of a Patient Advocate
Bob Riter explains how his breast cancer diagnosis set him on a path to find his calling.
by Bob Riter
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore